Kestra Medical Technologies Ratios (2024-2026) | KMTS

Ratios Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Profitability
Gross Margin (Quarter) 10.63%13.89%32.86%39.63%43.39%44.29%45.69%50.63%52.57%54.76%
EBT Margin (Quarter) -261.02%-221.91%-158.94%-140.13%-144.08%-248.05%-133.15%-145.14%-139.02%270.63%
EBIT Margin (Quarter) -240.98%-202.40%-144.19%-130.07%-136.52%-279.77%-149.08%-140.73%-141.60%-137.38%
EBITDA Margin (Quarter) -240.98%-202.40%-144.19%-130.07%-136.52%-279.77%-149.08%-140.73%-141.60%-137.38%
Operating Margin (Quarter) -240.98%-202.40%-144.19%-130.07%-136.52%-279.77%-149.08%-140.73%-141.60%-137.38%
Net Margin (Quarter) -283.09%-241.48%-174.21%-161.05%-164.57%-321.15%-133.32%-145.29%-139.16%-135.61%
FCF Margin (Quarter) -68.04%-136.83%-200.88%-57.87%-137.59%-135.58%-149.72%-114.71%21.28%
Efficiency
Assets Average (Quarter) 201.87M281.02M256.50M313.02M368.90M
Invested Capital (Quarter) 42.54M43.75M41.10M41.49M
Asset Utilization Ratio (Quarter) 0.300.240.290.270.26
Leverage & Solvency
Interest Coverage Ratio (Quarter) -12.07-10.52-9.84-8.26-11.55-11.74-15.10-0.67-1.00-21.34
Debt Ratio (Quarter) 0.930.410.140.160.170.110.12
Times Interest Earned (Quarter) -12.07-10.52-9.84-8.26-11.55-11.74-15.10-0.67-1.00-21.34
Valuation
Enterprise Value (Quarter) -15.35M-8.25M-99.97M-76.92M-38.19M-237.59M-201.21M-175.42M-291.32M-358.93M
Return Ratios
Return on Sales (Quarter) -0.03%-0.02%-0.02%-0.01%-0.01%-0.03%-0.01%-0.01%-0.01%0.03%
Return on Capital Employed (Quarter) -64.91%-46.96%-58.64%-53.17%-42.30%
Return on Invested Capital (Quarter) -0.01%-0.01%-0.01%-0.01%-0.01%-0.02%
Return on Assets (Quarter) -0.01%0.00%0.00%0.00%0.00%